Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HIV infection.
Bekker LG, Beyrer C, Mgodi N, Lewin SR, Delany-Moretlwe S, Taiwo B, Masters MC, Lazarus JV. Bekker LG, et al. Among authors: delany moretlwe s. Nat Rev Dis Primers. 2023 Aug 17;9(1):42. doi: 10.1038/s41572-023-00452-3. Nat Rev Dis Primers. 2023. PMID: 37591865 Review.
Preventing HIV among young people: research priorities for the future.
Pettifor A, Bekker LG, Hosek S, DiClemente R, Rosenberg M, Bull SS, Allison S, Delany-Moretlwe S, Kapogiannis BG, Cowan F; HIV Prevention Trials Network (HPTN) Adolescent Scientific Committee. Pettifor A, et al. J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2(0 2):S155-60. doi: 10.1097/QAI.0b013e31829871fb. J Acquir Immune Defic Syndr. 2013. PMID: 23764629 Free PMC article. Review.
Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.
Mujugira A, Magaret AS, Celum C, Baeten JM, Lingappa JR, Morrow RA, Fife KH, Delany-Moretlwe S, de Bruyn G, Bukusi EA, Karita E, Kapiga S, Corey L, Wald A; Partners in Prevention HSV/HIV Transmission Study Team. Mujugira A, et al. J Infect Dis. 2013 Nov 1;208(9):1366-74. doi: 10.1093/infdis/jit333. Epub 2013 Jul 30. J Infect Dis. 2013. PMID: 23901094 Free PMC article. Clinical Trial.
Response to "Oral PrEP for young African women and men".
Celum CL, Delany-Moretlwe S, McConnell M, van Rooyen H, Bekker LG, Kurth A, Bukusi E, Desmond C, Morton J, Baeten JM. Celum CL, et al. J Int AIDS Soc. 2016 Feb 25;19(1):20861. doi: 10.7448/IAS.19.1.20861. eCollection 2016. J Int AIDS Soc. 2016. PMID: 26928811 Free PMC article. No abstract available.
PrEP implementation research in Africa: what is new?
Cowan FM, Delany-Moretlwe S, Sanders EJ, Mugo NR, Guedou FA, Alary M, Behanzin L, Mugurungi O, Bekker LG. Cowan FM, et al. J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21101. doi: 10.7448/IAS.19.7.21101. eCollection 2016. J Int AIDS Soc. 2016. PMID: 27760680 Free PMC article.
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.
Delany-Moretlwe S, Lombard C, Baron D, Bekker LG, Nkala B, Ahmed K, Sebe M, Brumskine W, Nchabeleng M, Palanee-Philips T, Ntshangase J, Sibiya S, Smith E, Panchia R, Myer L, Schwartz JL, Marzinke M, Morris L, Brown ER, Doncel GF, Gray G, Rees H. Delany-Moretlwe S, et al. Lancet Infect Dis. 2018 Nov;18(11):1241-1250. doi: 10.1016/S1473-3099(18)30428-6. Epub 2018 Oct 24. Lancet Infect Dis. 2018. PMID: 30507409 Clinical Trial.
190 results